Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wushicha Keli (also known as Wushicha Granules or Noon Tea Granules) is a traditional Chinese medicine (TCM) OTC product developed and manufactured by Hubei Wushi Pharmaceutical. It is formulated as an oral granule and is widely used to treat the common cold (wind-cold type), headache, body aches, fever, abdominal pain, diarrhea, nausea, vomiting, and dyspepsia/food stagnation. The formula is a complex multi-herb mixture containing black tea (hong cha) as the chief ingredient, along with other traditional herbs such as Atractylodes lancea (cang zhu), Bupleurum chinense (chai hu), Notopterygium incisum (qiang huo), Saposhnikovia divaricata (fang feng), Angelica dahurica (bai zhi), Ligusticum chuanxiong (chuan xiong), Agastache rugosa (huoxiang), Peucedanum praeruptorum (qian hu), Forsythia suspensa (lian qiao), Citrus reticulata (chen pi), Crataegus pinnatifida (shan zha), Citrus aurantium (zhi shi), Hordeum vulgare (mai ya), Glycyrrhiza uralensis (gan cao), Platycodon grandiflorus (jie geng), Perilla frutescens (zi su ye), Magnolia officinalis (hou po), and Massa Medicata Fermentata (shen qu). It functions by dispelling wind, resolving the exterior, removing dampness, and harmonizing the middle burner.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Wushicha Keli.